MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/cid/ciae583

Медицинская библиотека · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025

NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study.

Cheli Stefania, Torre Alessandro, Schiuma Marco, Montrasio Cristina, Civati Aurora, Galimberti Miriam, Battini Vera, Mariani Ilaria, Mosini Giulia, Carnovale Carla, Radice Sonia, Clementi Emilio, Gori Andrea, Antinori Spinello

СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Under standard therapies, the incidence of drug-induced liver injury (DILI) in patients with tuberculosis ranges from 2% to 28%. Numerous studies have identified the risk factors for antituberculosis DILI; however, none have been conducted in a multiethnic real-world setting. The primary outcome of the current study was to identify the risk factors that could be used as the best predictors of DILI in a multiethnic cohort.

METHODS

A nested case-control study was conducted in patients at the tuberculosis clinic of Luigi Sacco Hospital in Milan.

RESULTS

The study included 102 patients (mean age [SD], 45.6 [15.6] years). For each patient with hepatotoxicity, 2 controls were matched for sex, age, body mass index, tuberculosis/tuberculosis infection diagnosis, and index date. We found that N-acetyltransferase 2 gene (NAT2) slow acetylator status was the best independent predictor of DILI (odds ratio, 5.97 [95% confidence interval, 1.38-25.76]; P = .02].

CONCLUSIONS

NAT2 genotype-guided dosing may help optimize antituberculosis drug treatment and prevent treatment failure.

CLINICAL TRIALS REGISTRATION: ClinicalTrials.gov NCT06539455.

Для цитирования: Cheli Stefania, Torre Alessandro, Schiuma Marco, Montrasio Cristina, Civati Aurora, Galimberti Miriam, Battini Vera, Mariani Ilaria, Mosini Giulia, Carnovale Carla, Radice Sonia, Clementi Emilio, Gori Andrea, Antinori Spinello. NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2025. DOI: 10.1093/cid/ciae583.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.